1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Fallopian Tube Adenocarcinoma: new trials by email Literature Review of Fallopian Tube Adenocarcinoma trials Research Report on Fallopian Tube Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery Oregovomab, Paclitaxel, Carboplatin - Carcinoma, Ovarian Epithelial, Ovarian Neoplasms | Phase 3 | Active not recruiting | CanariaBio Inc. | 615 | 2020-08-25 | 2026-04-01 |
Carcinoma, Ovarian Epithelial (1) · Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1) · Peritoneal Neoplasms (1)
Abdominal Neoplasms (1) · Adnexal Diseases (1) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Fallopian Tube Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1)
Carboplatin (1) · Paclitaxel (1) · oregovomab (1)
CanariaBio Inc. (1)
Argentina (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Czechia (1) · Hungary (1) · India (1) · Italy (1) · Mexico (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)